Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Oct 9, 2026Periodic report · 6-KFiled by the company itself.Open the filing ↗
- Oct 8, 2026Periodic report · 6-KFiled by the company itself.Open the filing ↗
- Oct 8, 2026Periodic report · 6-KFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year132
SEC filings on record15314 flagged findings
Reported transactions (Form 4)0and 1 other holding
Corporate events (8-K)0
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-06-01share offering or dilution eventrecentOpen filing ↗“…June 1, 2026, China SXT Pharmaceuticals, Inc. (the “Company”) entered into a certain sales agreement (the “Sales Agreement”) with…”
+1 more passage from the same document
- “…described therein has been suspended, cancelled or otherwise terminated. The Sales Agent’s obligation to sell Class A Ordinary…”
- 2026-06-01listing compliance noticerecentOpen filing ↗“…published, official guidance and related implementation rules have not been issued. It is highly uncertain what the potential…”
+1 more passage from the same document
- “…to these determinations. On June 22, 2021, United States Senate has passed the Accelerating Holding Foreign Companies…”
- 2026-06-01capital return (buybacks/dividends)recentOpen filing ↗“…provide otherwise in the prospectus supplement or free writing prospectus applicable to a particular series of debt securities, the…”
+1 more passage from the same document
- “…securities may be listed. Sale Through Underwriters or Dealers Only underwriters named in the prospectus supplement are underwriters…”
- 2026-06-01reverse splitrecentOpen filing ↗“…dilution to the extent of the difference between the public offering price of the Class A Ordinary Shares in this offering…”
+1 more passage from the same document
- “…the sum of liabilities and intangible assets. “Net tangible book value per share” is net tangible book value divided by the total…”
- 2026-05-04share offering or dilution eventrecentOpen filing ↗“…Persons” (as defined in Regulation S of the Securities Act of 1933, as amended) (the “Purchasers”) for a private placement…”
- 2026-04-09listing compliance noticerecentOpen filing ↗“…published, official guidance and related implementation rules have not been issued. It is highly uncertain what the potential…”
+1 more passage from the same document
- “…to these determinations. On June 22, 2021, United States Senate has passed the Accelerating Holding Foreign Companies…”
- 2026-04-09capital return (buybacks/dividends)recentOpen filing ↗“…provide otherwise in the prospectus supplement or free writing prospectus applicable to a particular series of debt securities, the…”
+1 more passage from the same document
- “…securities may be listed. Sale Through Underwriters or Dealers Only underwriters named in the prospectus supplement are underwriters…”
- 2026-04-09reverse splitrecentOpen filing ↗“…market funds. CAPITALIZATION AND INDEBTEDNESS The following table sets forth our capitalization as of September 30, 2025: ● on an…”
+1 more passage from the same document
- “…other comprehensive loss (766,991 ) (766,991 (766,991 ) Total Shareholders’ Equity 20,233,535 29,343,535 30,103,535 Total…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
Reverse splits in 5 years
4 reverse splits in 5 years (1:20 on May 19, 2022, 1:25 on Oct 5, 2023, 1:8 on Feb 25, 2025, 1:150 on Feb 3, 2026) · 1:600000 cumulative
The other times: of 214 securities that repeated a reverse split in 5 years, a year later the median was worth 0.10× the price on the day of the split; 166 lost more than half and 20 rose (214 with a price a year later).
Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.
The 25 most recent filings (of 153)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Oct 15, 26SCHEDULE 13G ↗Passive stake · Orca Capital AG · 9.9% · event on Oct 8, 26 new
- Oct 9, 266-K ↗Foreign issuer report
- Oct 9, 26424B5 ↗Securities offering
- Oct 8, 266-K ↗Foreign issuer report
- Oct 8, 266-K ↗Foreign issuer report
- Aug 28, 26F-3/A ↗Securities offering · amendment
- Aug 28, 266-K ↗Foreign issuer report
- Jul 24, 266-K ↗Foreign issuer report
- Jul 24, 26424B5 ↗Securities offering
- Jul 7, 26F-3 ↗Securities offering
- Jul 6, 266-K ↗Foreign issuer report
- Jul 1, 2620-F ↗Annual report
- Jun 1, 266-K ↗Foreign issuer report
- Jun 1, 26424B5 ↗Securities offering
- May 4, 266-K ↗Foreign issuer report
Insider transaction · 7 Form 3 filingsshow all 7hide
- Apr 9, 26424B5 ↗Securities offering
- Apr 9, 266-K ↗Foreign issuer report
- Jan 13, 266-K ↗Foreign issuer report
153 filings on record, the oldest from Dec 4, 17.
Listing the 25 most recent filings of the 153 on record.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- Orca Capital AG9.9%Oct 8, 26SCHEDULE 13G ↗
- FOONG SOON HONG, RANDY9.1%Jul 29, 25SCHEDULE 13G ↗
- TAN SOO SENG8.9%Jul 29, 25SCHEDULE 13G ↗
- TAN CHENG GUAN8.8%Jul 29, 25SCHEDULE 13G ↗
- CHING CHOON HWA8.4%Jul 29, 25SCHEDULE 13G ↗
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Its sector and its market
China SXT Pharmaceuticals, Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From China SXT Pharmaceuticals, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow China SXT Pharmaceuticals, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- Series with incidents in the period; the chart shows what could be kept.
- SEC records
- 153 documents on file, from Dec 4, 2017 to Oct 15, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.